139 related articles for article (PubMed ID: 37039979)
1. Quantitative Prediction of Posttransplant Hepatocellular Carcinoma Prognosis Using ADV Score: Validation with Korea-Nationwide Transplantation Registry Database.
Park GC; Hwang S; You YK; Choi Y; Kim JM; Joo DJ; Ryu JH; Choi D; Kim BW; Kim DS; Nah YW; Kang KJ; Cho JY; Yu HC; Kim DG
J Gastrointest Surg; 2023 Jul; 27(7):1353-1366. PubMed ID: 37039979
[TBL] [Abstract][Full Text] [Related]
2. Validation of quantitative prognostic prediction using ADV score for resection of hepatocellular carcinoma: A Korea-Japan collaborative study with 9200 patients.
Kang WH; Hwang S; Kaibori M; Kim JM; Kim KS; Kobayashi T; Kayashima H; Koh YS; Kubota K; Mori A; Takeda Y; Yun SS; Matsui K; Toriguchi K; Nagano H; Yoon MH; Soejima Y; Ariizumi S; Kim BS; Park Y; Yu HC; Kim BW; Lee JB; Park SJ; Jang JY; Yamaue H; Nakamura M; Yamamoto M; Endo I; ;
J Hepatobiliary Pancreat Sci; 2023 Aug; 30(8):993-1005. PubMed ID: 36808234
[TBL] [Abstract][Full Text] [Related]
3. Quantitative Prognostic Prediction Using ADV Score for Hepatocellular Carcinoma Following Living Donor Liver Transplantation.
Hwang S; Song GW; Ahn CS; Kim KH; Moon DB; Ha TY; Jung DH; Park GC; Yoon YI; Lee SG
J Gastrointest Surg; 2021 Oct; 25(10):2503-2515. PubMed ID: 33532981
[TBL] [Abstract][Full Text] [Related]
4. Salvage living donor liver transplantation for hepatocellular carcinoma recurrence after hepatectomy: Quantitative prediction using ADV score.
Hwang S; Song GW; Ahn CS; Kim KH; Moon DB; Ha TY; Jung DH; Park GC; Yoon YI; Lee SG
J Hepatobiliary Pancreat Sci; 2021 Nov; 28(11):1000-1013. PubMed ID: 33175453
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Accuracy of the ADV Score Following Resection of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis.
Hwang S; Moon DB; Kim KH; Ahn CS; Song GW; Jung DH; Park GC; Lee SG
J Gastrointest Surg; 2021 Jul; 25(7):1745-1759. PubMed ID: 32948961
[TBL] [Abstract][Full Text] [Related]
6. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
[TBL] [Abstract][Full Text] [Related]
7. Validation of prognostic impact of ADV score for resection of hepatocellular carcinoma: analysis using Korea Liver Cancer Registry Database.
Park GC; Hwang S; Park YH; Choi JU;
Ann Surg Treat Res; 2020 May; 98(5):235-246. PubMed ID: 32411628
[TBL] [Abstract][Full Text] [Related]
8. Multiplication of Tumor Volume by Two Tumor Markers Is a Post-Resection Prognostic Predictor for Solitary Hepatocellular Carcinoma.
Hwang S; Song GW; Lee YJ; Kim KH; Ahn CS; Moon DB; Ha TY; Jung DH; Park GC; Lee SG
J Gastrointest Surg; 2016 Nov; 20(11):1807-1820. PubMed ID: 27311982
[TBL] [Abstract][Full Text] [Related]
9. Small Hepatocellular Carcinoma With Low Tumor Marker Expression Benefits More From Anatomical Resection Than Tumors With Aggressive Biology.
Jung DH; Hwang S; Lee YJ; Kim KH; Song GW; Ahn CS; Moon DB; Lee SG
Ann Surg; 2019 Mar; 269(3):511-519. PubMed ID: 28837444
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of serum soluble PD-1 and ADV score for living donor liver transplantation in patients with previously untreated hepatocellular carcinoma.
Hwang S; Lee KJ; Moon DB; Song GW; Jung DH; Kim YK; Yang H; An DE; Lee S; Lee SG
Ann Surg Treat Res; 2022 Jan; 102(1):46-54. PubMed ID: 35071119
[TBL] [Abstract][Full Text] [Related]
11. Outcome of ABO-incompatible adult living-donor liver transplantation for patients with hepatocellular carcinoma.
Yoon YI; Song GW; Lee SG; Hwang S; Kim KH; Kim SH; Kang WH; Cho HD; Jwa EK; Kwon JH; Tak EY; Kirchner VA
J Hepatol; 2018 Jun; 68(6):1153-1162. PubMed ID: 29452208
[TBL] [Abstract][Full Text] [Related]
12. Validation of a Risk Estimation of Tumor Recurrence After Transplant (RETREAT) Score for Hepatocellular Carcinoma Recurrence After Liver Transplant.
Mehta N; Heimbach J; Harnois DM; Sapisochin G; Dodge JL; Lee D; Burns JM; Sanchez W; Greig PD; Grant DR; Roberts JP; Yao FY
JAMA Oncol; 2017 Apr; 3(4):493-500. PubMed ID: 27838698
[TBL] [Abstract][Full Text] [Related]
13. Alpha-fetoprotein level > 1000 ng/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria.
Hameed B; Mehta N; Sapisochin G; Roberts JP; Yao FY
Liver Transpl; 2014 Aug; 20(8):945-51. PubMed ID: 24797281
[TBL] [Abstract][Full Text] [Related]
14. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
[No Abstract] [Full Text] [Related]
15. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.
Meguro M; Mizuguchi T; Nishidate T; Okita K; Ishii M; Ota S; Ueki T; Akizuki E; Hirata K
World J Gastroenterol; 2015 Apr; 21(16):4933-45. PubMed ID: 25945007
[TBL] [Abstract][Full Text] [Related]
16. Do We Need to Be Limited by Matching Milan Criteria for Survival in Living Donor Liver Transplantation?
Akbulut S; Koc C
J Gastrointest Cancer; 2020 Dec; 51(4):1107-1113. PubMed ID: 32857265
[TBL] [Abstract][Full Text] [Related]
17. Evaluation methods for pretransplant oncologic markers and their prognostic impacts in patient undergoing living donor liver transplantation for hepatocellular carcinoma.
Shindoh J; Sugawara Y; Nagata R; Kaneko J; Tamura S; Aoki T; Sakamoto Y; Hasegawa K; Tanaka T; Kokudo N
Transpl Int; 2014 Apr; 27(4):391-8. PubMed ID: 24472068
[TBL] [Abstract][Full Text] [Related]
18. Prediction of Post-resection Prognosis Using the ADV Score for Huge Hepatocellular Carcinomas ≥13 cm.
Hwang S; Kim KH; Moon DB; Ahn CS; Ha TY; Song GW; Jung DH; Park GC
J Liver Cancer; 2021 Mar; 21(1):45-57. PubMed ID: 37384269
[TBL] [Abstract][Full Text] [Related]
19. The ratio of preoperative alpha-fetoprotein level to total tumor volume as a prognostic factor of hepatocellular carcinoma after liver transplantation.
Jiang T; Zhang XS; Pan F; Lyu SC; Wang J; Huang MX; He Q; Lang R
Medicine (Baltimore); 2021 Jul; 100(26):e26487. PubMed ID: 34190174
[TBL] [Abstract][Full Text] [Related]
20. The AGH score is a predictor of disease-free survival and targeted therapy efficacy after liver transplantation in patients with hepatocellular carcinoma.
Li JH; Chen T; Xing H; Li RD; Shen CH; Zhang QB; Tao YF; Wang ZX
Hepatobiliary Pancreat Dis Int; 2023 Jun; 22(3):245-252. PubMed ID: 35534342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
